| Literature DB >> 24808180 |
Ilker Karaca1, Irfan Y Tamboli1, Konstantin Glebov1, Josefine Richter2, Lisa H Fell3, Marcus O Grimm3, Viola J Haupenthal3, Tobias Hartmann3, Markus H Gräler4, Gerhild van Echten-Deckert5, Jochen Walter6.
Abstract
Progressive accumulation of the amyloid β protein in extracellular plaques is a neuropathological hallmark of Alzheimer disease. Amyloid β is generated during sequential cleavage of the amyloid precursor protein (APP) by β- and γ-secretases. In addition to the proteolytic processing by secretases, APP is also metabolized by lysosomal proteases. Here, we show that accumulation of intracellular sphingosine-1-phosphate (S1P) impairs the metabolism of APP. Cells lacking functional S1P-lyase, which degrades intracellular S1P, strongly accumulate full-length APP and its potentially amyloidogenic C-terminal fragments (CTFs) as compared with cells expressing the functional enzyme. By cell biological and biochemical methods, we demonstrate that intracellular inhibition of S1P-lyase impairs the degradation of APP and CTFs in lysosomal compartments and also decreases the activity of γ-secretase. Interestingly, the strong accumulation of APP and CTFs in S1P-lyase-deficient cells was reversed by selective mobilization of Ca(2+) from the endoplasmic reticulum or lysosomes. Intracellular accumulation of S1P also impairs maturation of cathepsin D and degradation of Lamp-2, indicating a general impairment of lysosomal activity. Together, these data demonstrate that S1P-lyase plays a critical role in the regulation of lysosomal activity and the metabolism of APP.Entities:
Keywords: Alzheimer Disease; Amyloid; Amyloid Precursor Protein (APP); Lysosome; Sphingolipid; Sphingosine-1-phosphate (S1P)
Mesh:
Substances:
Year: 2014 PMID: 24808180 PMCID: PMC4059120 DOI: 10.1074/jbc.M113.535500
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157